InvestorsHub Logo
Followers 57
Posts 5700
Boards Moderated 0
Alias Born 12/13/2004

Re: 1776club post# 12460

Tuesday, 01/04/2022 4:52:02 PM

Tuesday, January 04, 2022 4:52:02 PM

Post# of 14947
I agree with the great potential for SOFUSA. They seem to be highlighting two programs. Anti-TNF to treat arthritis...and anti-PD1 against CTCL which is an orphan cancer indication. Elsewhere they have said that they have pre-clinical data on file from multiple pre-clinical studies involving etanercept, trastuzumab, CTLA-4, PD-1, and PD-L1.

"The refusal of the real is the number one dogma of our time" Rene Girard

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SRNE News